Artiva Biotherapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Artiva Biotherapeutics announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and an equity incentive plan amendment.
NASDAQ
Artiva Biotherapeutics will hold its annual stockholders meeting on June 24, 2025, to vote on director election, auditor ratification, and an equity incentive plan amendment.
NASDAQ
Artiva Biotherapeutics is holding its annual meeting to elect a director, ratify the appointment of its auditor, and approve an amendment to its equity incentive plan.